Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW January 2001

Volume 10
Issue Number 1
January 2001
ISSN 10593802

Effect of Tamoxifen in BRCA Mutation Carriers

Mutation in BRCA1 or BRCA2 gene increases the risk of developing breast cancer and contralateral cancer after the initial diagnosis. Tamoxifen has been shown to protect against contralateral breast cancer among high-risk women with BRCA mutations.
Go to Previous Page
Go to Next Page

Source & Additional Reading

S. A. Narod et al., The Lancet, December 2, 2000.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW January 2001

Purchase Downloadable Full-text PDF of Complete Issue: $10.00

<< Go Back to CW January 2001